Foghorn Therapeutics (FHTX) Other Non-Current Assets (2019 - 2026)

Foghorn Therapeutics' Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $3000.0 for Q1 2026.

• In Q1 2026, Other Non-Current Assets fell 87.5% year-over-year to $3000.0; the TTM figure through Mar 2026 stood at $3000.0 (down 87.5% YoY), while the FY2025 annual figure was $4000.0, down 99.77% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $3000.0, down from $4000.0 in the prior quarter.
• The five-year high for Other Non-Current Assets was $2.4 million in Q1 2022, with the low at $3000.0 in Q1 2026.
• The 5-year median for Other Non-Current Assets is $1.7 million (2022), against an average of $1.3 million.
• Peak annual rise in Other Non-Current Assets reached 135.85% in 2025, while the deepest fall reached 99.77% in 2025.
• Foghorn Therapeutics' Other Non-Current Assets stood at $1.7 million in 2022, then slumped by 34.72% to $1.1 million in 2023, then soared by 53.18% to $1.7 million in 2024, then sank by 99.77% to $4000.0 in 2025, then retreated by 25.0% to $3000.0 in 2026.
• Business Quant data shows FHTX's Other Non-Current Assets at $3000.0 in Q1 2026, $4000.0 in Q4 2025, and $2.0 million in Q3 2025.